aggrastat
tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate - solution for infusion - tirofiban as hydrochloride monohydrate 0.05 mg/ml - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.
aggrastat 0.25mg/ml i.v. vial concentrate for solution for infusion
algorithm sal, lebanon - tirofiban - concentrate for solution for infusion - 0.25 mg/ml
aggrastat 0.25mg\ml i.v vial injection
merck sharp & dohme - tirofiban - injection - 0.25 mg/ml
agriplat 12.5 mg solution for infusion concentrate for solution for infusion
tabuk pharmaceutical manufacturing co., saudi arabia - tirofiban - concentrate for solution for infusion - 0.25 mg/ml
aggrastat concentrate for infusion 0.25mg/ml 0.25 mg/ml
مستودع أدوية أداتكو - adatco drug store - tirofiban 0.25 mg/ml - 0.25 mg/ml
ribofan 0.25mg /ml
شركة ام اس فارما - ms pharma - tirofiban 0.25mg /ml - 0.25mg /ml
aggrastat 0.05mg/ml solution, solution for intravenous infusion
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for infusion - tirofiban 50 µg - antithrombotic agents
agriplat 12.5 mg solution for infusion concentrate for solution for infusion
tabuk pharmaceutical manufacturing company, saudi arabia - tirofiban - concentrate for solution for infusion - 0.25 mg/ml
aggrastat 0.25mg/ml i.v. vial concentrate for solution for infusion
algorithm sal, lebanon - tirofiban - concentrate for solution for infusion - 0.25 mg/ml
fibrostat 281.0 mcg/1 ml
شركة أدوية الحكمة - hikma pharmaceuticals - tirofiban hcl 281.0 mcg/1 ml - 281.0 mcg/1 ml